UN Security Council
2021

pandemics, in particular by enabling equitable global access to quality, safe, efficacious and affordable diagnostics, therapeutics, medicines and vaccines, and essential health technologies, and their components, as well as equipment for the COVID-19 response, in situations of armed conflict, post-conflict situations, and complex humanitarian emergencies, and taking into account the need to maintain incentives for the development of new health products, Highlighting the World Health Organisation (WHO) call that as new variants arise there should be increased scientific collaboration, transparency, exchange of information and sharing scientific knowledge including of epidemiology and genomic sequencing data, and equitable access to COVID-19 health products, and recognising in that respect the crucial role of the WHO and the importance of the Access to COVID-19 Tools Accelerator (ACT-A), Stressing that equitable access to safe, efficacious, and affordable COVID -19 vaccines is essential to end the pandemic, noting the need to maintain incentives for the development of new health products, and highlighting the impediments to vaccination, including gaps in financing, supply, manufacturing capacity, delivery,